Samsara Inc.: Form 10-Q for the period ended Apr 30, 2022
Filed with the SEC on Jun 8, 2022 and accepted by EDGAR at Jun 8, 2022, 20:14 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-04-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2022-01-30 to 2022-04-30 | $142.6m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2022-01-30 to 2022-04-30 | $39.6m | us-gaap:CostOfRevenue |
| Gross profit | 3 months2022-01-30 to 2022-04-30 | $103.0m | us-gaap:GrossProfit |
| Research and development | 3 months2022-01-30 to 2022-04-30 | $41.0m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2022-01-30 to 2022-04-30 | −$70.2m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2022-01-30 to 2022-04-30 | $723.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2022-01-30 to 2022-04-30 | −$71.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2022-01-30 to 2022-04-30 | −$0.14 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2022-01-30 to 2022-04-30 | −$0.14 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2022-01-30 to 2022-04-30 | 507,295,982 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2022-01-30 to 2022-04-30 | −$48.8m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2022-01-30 to 2022-04-30 | $10.7m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 3 months2022-01-30 to 2022-04-30 | $0 | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2022-04-30 | $859.8m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2022-04-30 | $1.07bn | us-gaap:AssetsCurrent |
| Total assets | At period end2022-04-30 | $1.54bn | us-gaap:Assets |
| Current liabilities | At period end2022-04-30 | $352.3m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2022-04-30 | $582.5m | us-gaap:Liabilities |
| Shareholders' equity | At period end2022-04-30 | $962.4m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001642896-22-000040. Last ingested by Listed: Nov 15, 2026, 00:51 ET. Listed shows no prices and gives no investment advice.